CSTL vs BLLN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CSTL · Castle Biosciences$32.86 ▼ 1.63%
BLLN · BillionToOne$89.92 ▼ 0.31%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CSTL -14.6%
- BLLN -25.0%
Head to head
| Metric | CSTL | BLLN |
|---|---|---|
| Price | $32.86 | $89.92 |
| Change today | ▼ 1.63% | ▼ 0.31% |
| Market cap | $1.01B | $4.30B |
| Return, 3 months | -1.8% | -7.0% |
| Return, year to date | -15.5% | +9.9% |
| Return, 1 year | -13.3% | -18.3% |
| P/E (TTM) | – | 93.2 |
| P/B | 2.1 | 7.6 |
| P/E percentile vs own 5y | 32nd | 46th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +23.9% | +47.2% |
| Net profit growth (YoY) | -718.4% | +204.5% |
| Gross margin | 77.1% | 71.4% |
| Operating margin | -7.4% | 10.2% |
| Net margin | -6.1% | 10.5% |
| Return on equity | -4.9% | 28.1% |
| Analyst target vs. price | +47.0% | +46.4% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 45 | 30 |
| 30-day volatility | 52.8% | 51.2% |
| Max drawdown, 1 year | -57.8% | -50.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BLLN is the largest of the group by market value.
- CSTL has returned the most over the past year.
- BLLN is growing revenue fastest.
- BLLN keeps the most profit per dollar of sales.
- BLLN has been the calmest stock over the last 30 days.